Literature DB >> 15965286

Plasmacytoma of the lung: an indolent disease resistant to conventional myeloma treatment: report of a case.

D Marisavljevic1, O Markovic, V Cemerkic-Martinovic, D Ponomarev.   

Abstract

Solitary lung plasmacytoma is a rare form of plasma cell tumors. The case of a 56-yr-old man is presented, who had a massive tumor of the right pulmonary apex. Percutaneous transthoracic lung biopsy demonstrated a tumor-cell population consisting of mature plasma cells, proplasmacytes, and rare plasmablasts. Immunohistochemically, the cells were CD79a+, kappa+, cyclin D1-, p53-, MDR-. Proliferative index was low (number of Ki-67+ tumor cells was 8%). Serum and urine immunoelectrophoresis did not show the presence of paraprotein. Screening for multiple myeloma with skeletal X-ray survey and bone marrow biopsy were negative. Radiotherapy and chemotherapy with alkylating agents were ineffective. However, the course of the disease is indolent and the patient is well, alive, and with no signs of multiple myeloma >5 yr after the diagnosis was established. Some pathogenetic aspects of tumor resistance to conventional myeloma treatment in this case are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15965286     DOI: 10.1385/MO:22:2:207

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  10 in total

Review 1.  Radiotherapy in the management of plasma cell tumors.

Authors:  K Hu; J Yahalom
Journal:  Oncology (Williston Park)       Date:  2000-01       Impact factor: 2.990

2.  Diverse roentgenographic manifestations of the rare pulmonary involvement in myeloma.

Authors:  M S Shin; M F Carcelen; K J Ho
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

3.  Extramedullary plasmacytoma. A form of marginal zone cell lymphoma?

Authors:  J W Hussong; S L Perkins; B Schnitzer; H Hargreaves; G Frizzera
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

4.  Response of the extramedullary lung plasmacytoma with pleural effusion to chemotherapy.

Authors:  K Nagai; K Ando; H Yoshida; S Kusaka; Y Hinuma; Y Hakamata; K Ishii; N Kume; H Ochi; Y Wakatsuki; M Yokode; M Murakami; T Kita
Journal:  Ann Hematol       Date:  1997-06       Impact factor: 3.673

5.  Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome.

Authors:  R W Tsang; M K Gospodarowicz; M Pintilie; A Bezjak; W Wells; D C Hodgson; A K Stewart
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-05-01       Impact factor: 7.038

6.  Clinical course of solitary extramedullary plasmacytoma.

Authors:  R H Liebross; C S Ha; J D Cox; D Weber; K Delasalle; R Alexanian
Journal:  Radiother Oncol       Date:  1999-09       Impact factor: 6.280

Review 7.  [Pulmonary plasmacytoma. Apropos of a case. Review of the literature].

Authors:  G Etienne; X Révolte; O Lagrange; B Fond; P Belin
Journal:  Rev Pneumol Clin       Date:  1995

8.  Solitary secretory plasmacytoma of the lung in a 14-year-old boy.

Authors:  C D Baroni; T C Mineo; C Ricci; S Guarino; F Mandelli
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

9.  Primary pulmonary plasmacytoma with lobar consolidation: an unusual presentation.

Authors:  K Y Chen; H D Wu; Y L Chang; J Y Shih; P C Yang
Journal:  J Formos Med Assoc       Date:  1998-07       Impact factor: 3.282

10.  Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance.

Authors:  O Markovic; D Marisavljevic; V Cemerikic; N Suvajdzic; N Milic; M Colovic
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

  10 in total
  2 in total

1.  Radioresistant Extramedullary Plasmacytoma of the Maxillary Sinus: A Case Report and review article.

Authors:  Matin Ghazizadeh; Hesamodin Alavi Amlashi; Golfam Mehrparvar
Journal:  Iran J Otorhinolaryngol       Date:  2015-07

2.  Primary pulmonary plasmacytoma accompanied by overlap syndrome: A case report and review of the literature.

Authors:  Yi Zhou; Xiao-Hong Wang; Shuang-Shuang Meng; Hui-Chao Wang; Yu-Xia Li; Rui Xu; Xu-Hong Lin
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.